VistaGen Therapeutics (VTGN)
(Delayed Data from NSDQ)
$4.48 USD
+0.03 (0.67%)
Updated May 9, 2024 04:00 PM ET
After-Market: $4.49 +0.01 (0.22%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 6/26/24 |
---|---|
Current Quarter | -0.34 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | 29.03% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.56 |
Next Year | -2.00 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.41M | 0.40M | 1.13M | 0.41M |
# of Estimates | 2 | 1 | 3 | 2 |
High Estimate | 0.41M | 0.40M | 1.28M | 0.41M |
Low Estimate | 0.40M | 0.40M | 0.90M | 0.40M |
Year ago Sales | NA | 0.18M | NA | 1.13M |
Year over Year Growth Est. | NA | 122.22% | NA | -64.03% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.34 | -0.37 | -1.56 | -2.00 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | -0.27 | -0.38 | -1.46 | -2.05 |
High Estimate | -0.27 | -0.36 | -1.46 | -1.89 |
Low Estimate | -0.46 | -0.38 | -1.74 | -2.07 |
Year ago EPS | NA | -0.94 | -8.51 | -1.56 |
Year over Year Growth Est. | NA | 60.64% | 81.67% | -28.63% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Current | -0.34 | -0.37 | -1.56 | -2.00 |
7 Days Ago | -0.34 | -0.37 | -1.56 | -2.00 |
30 Days Ago | -0.34 | -0.37 | -1.56 | -2.00 |
60 Days Ago | -0.34 | -0.37 | -1.56 | -2.00 |
90 Days Ago | -0.42 | -0.51 | -1.86 | -2.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.34 | -0.37 | -1.56 | -2.00 |
Zacks Consensus Estimate | -0.34 | -0.37 | -1.56 | -2.00 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.66 | -0.94 | NA | NA |
Estimate | -0.31 | NA | NA | NA | NA |
Difference | 0.09 | NA | NA | NA | 0.09 |
Surprise | 29.03% | NA | NA | NA | 29.03% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more